300396 Stock Overview
Engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Dirui Industrial Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.89 |
| 52 Week High | CN¥33.26 |
| 52 Week Low | CN¥12.69 |
| Beta | 0.19 |
| 11 Month Change | -2.34% |
| 3 Month Change | -1.85% |
| 1 Year Change | -47.75% |
| 33 Year Change | -4.91% |
| 5 Year Change | n/a |
| Change since IPO | -27.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300396 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -8.0% | -5.6% | -6.7% |
| 1Y | -47.7% | -10.2% | 1.9% |
Return vs Industry: 300396 underperformed the CN Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 300396 underperformed the CN Market which returned 4% over the past year.
Price Volatility
| 300396 volatility | |
|---|---|
| 300396 Average Weekly Movement | 10.1% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 300396 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300396's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 2,092 | Xuemin Wang | www.dirui.com.cn |
Dirui Industrial Co.,Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments and supporting test strip reagents.
Dirui Industrial Co.,Ltd. Fundamentals Summary
| 300396 fundamental statistics | |
|---|---|
| Market cap | CN¥4.30b |
| Earnings (TTM) | CN¥233.88m |
| Revenue (TTM) | CN¥1.50b |
18.4x
P/E Ratio2.9x
P/S RatioIs 300396 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300396 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.50b |
| Cost of Revenue | CN¥833.32m |
| Gross Profit | CN¥671.58m |
| Other Expenses | CN¥437.70m |
| Earnings | CN¥233.88m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.86 |
| Gross Margin | 44.63% |
| Net Profit Margin | 15.54% |
| Debt/Equity Ratio | 18.4% |
How did 300396 perform over the long term?
See historical performance and comparison